Skip to main content
OpenTrials

Clinical trial condition

Esophageal Diseases

Explore clinical trials studying Esophageal Diseases. Study availability and eligibility vary by location and protocol.

3,518 public trials 713 recruiting studies
Refine in advanced search Browse all conditions

Esophageal Diseases trial results

Recruiting

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

NCT07277413

Conditions
Adenocarcinoma Of Esophagus, Adenocarcinoma of Esophagus, Adenoma, +55 more
Locations
  • Providence Medical Foundation Santa Rosa, California, United States
  • Johns Hopkins Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • BRCR Global-Coral Springs Coral Springs, Florida, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
View all 16 locations
View Trial Details
Recruiting

APG-2449 in Patients With Advanced Solid Tumors

NCT03917043

Conditions
Adenoma, Adnexal Diseases, Advanced Solid Cancer, +39 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun-Yat Sen University Cancer Center Guangzhou, Guangdong, China
View Trial Details
Recruiting

Treatment Outcomes of Esophageal Cancer

NCT05177393

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +7 more
Locations
  • Tenwek Hospital Bomet, Kenya
  • Moi Teaching and Referral Hospital Eldoret, Kenya
  • Kamuzu Central Hospital Lilongwe, Malawi
  • Muhimbili National Hospital Dar es Salaam, Tanzania
View Trial Details
Recruiting

DESTINY-PANTUMOUR04

NCT07124000

Conditions
Adenocarcinoma, Adenocarcinoma (NOS), Adnexal Diseases, +116 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Bullhead City, Arizona, United States
  • Research Site Casa Grande, Arizona, United States
  • Research Site San Diego, California, United States
View all 18 locations
View Trial Details
Recruiting

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

NCT07090499

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, +50 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
View all 30 locations
View Trial Details
Recruiting

A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States

NCT07554521

Conditions
Advanced Gastroesophageal Adenocarcinoma, Advanced Unresectable Gastric Adenocarcinoma, Carcinoma, +14 more
Locations
  • Los Angeles Cancer Network Los Angeles, California, United States
  • Bioresearch Partners Holding Hialeah Hospital Hialeah, Florida, United States
  • Florida Clinical Trials Group Plantation Plantation, Florida, United States
  • Florida Clinical Trials Group Tamarac Tamarac, Florida, United States
View Trial Details
Recruiting

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

NCT05208762

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +47 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham, IDS Pharmacy Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
View all 62 locations
View Trial Details

Related conditions